Abstract
In this issue of Blood, Hirayama and colleagues report that a favorable cytokine profile induced by lymphodepletion is associated with durable remissions in patients with aggressive non-Hodgkin lymphoma treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1799-1800 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 133 |
| Issue number | 17 |
| DOIs | |
| State | Published - Apr 25 2019 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology
Fingerprint
Dive into the research topics of 'CAR-T efficacy: Is conditioning the key?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS